Translating science into medicine
Investors 2
| Date | Name | Website |
| - | E&Inve... | eninvestme... |
| - | AJU IB Inv... | ajuib.co.k... |
Mentions in press and media 1
| Date | Title | Description |
| 24.02.2023 | Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib | With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evalua... |